content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001801917</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
          <com:city>HAMILTON HM11</com:city>
          <com:stateOrCountry>D0</com:stateOrCountry>
          <com:zipCode>HM11</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>441-295-5950</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Venker Eric</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza</com:street1>
            <com:street2>Floor 5</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>100000</noOfUnitsSold>
        <aggregateMarketValue>1148554.35</aggregateMarketValue>
        <noOfUnitsOutstanding>727949744</noOfUnitsOutstanding>
        <approxSaleDate>11/20/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <acquiredDate>12/20/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Options Exercise - Grant Date 4/20/2022</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>100000</amountOfSecuritiesAcquired>
        <paymentDate>12/20/2024</paymentDate>
        <natureOfPayment>Wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Eric Venker c/o Roivant Sciences LTD</name>
          <address>
            <com:street1>7th Floor, 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1HoDB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>10/21/2024</saleDate>
        <amountOfSecuritiesSold>100000</amountOfSecuritiesSold>
        <grossProceeds>1165393.15</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Eric Venker c/o Roivant Sciences LTD</name>
          <address>
            <com:street1>7th Floor, 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>10/20/2024</saleDate>
        <amountOfSecuritiesSold>10945</amountOfSecuritiesSold>
        <grossProceeds>130464.40</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Eric Venker c/o Roivant Sciences LTD</name>
          <address>
            <com:street1>7th Floor, 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>09/20/2024</saleDate>
        <amountOfSecuritiesSold>10945</amountOfSecuritiesSold>
        <grossProceeds>131011.65</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Eric Venker c/o Roivant Sciences LTD</name>
          <address>
            <com:street1>7th Floor, 50 Broadway,</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0D</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>11/20/2024</saleDate>
        <amountOfSecuritiesSold>100000</amountOfSecuritiesSold>
        <grossProceeds>1132008.17</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Eric Venker c/o Roivant Sciences LTD</name>
          <address>
            <com:street1>7th Floor, 50 Broadway,</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0D</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common shares</securitiesClassTitle>
        <saleDate>11/20/2024</saleDate>
        <amountOfSecuritiesSold>10945</amountOfSecuritiesSold>
        <grossProceeds>125758.05</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/25/2024.</remarks>
      <noticeSignature>
        <noticeDate>12/20/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>06/25/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 6275}]
text: 144
  0001801917
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  CLARENDON HOUSE, 2 CHURCH STREET
  HAMILTON HM11
  D0
  HM11
  441-295-5950
  Venker Eric
  Officer
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza
  Floor 5
  New York
  NY
  10111
  100000
  1148554.35
  727949744
  11/20/2024
  NASDAQ
  Common Shares
  12/20/2024
  Options Exercise - Grant Date 4/20/2022
  Roivant Sciences Ltd.
  N
  100000
  12/20/2024
  Wire
  N
  Eric Venker c/o Roivant Sciences LTD
  7th Floor, 50 Broadway
  London
  X0
  SW1HoDB
  Common Shares
  10/21/2024
  100000
  1165393.15
  Eric Venker c/o Roivant Sciences LTD
  7th Floor, 50 Broadway
  London
  X0
  SW1H 0DB
  Common Shares
  10/20/2024
  10945
  130464.40
  Eric Venker c/o Roivant Sciences LTD
  7th Floor, 50 Broadway
  London
  X0
  SW1H0DB
  Common Shares
  09/20/2024
  10945
  131011.65
  Eric Venker c/o Roivant Sciences LTD
  7th Floor, 50 Broadway,
  London
  X0
  SW1H 0D
  Common Shares
  11/20/2024
  100000
  1132008.17
  Eric Venker c/o Roivant Sciences LTD
  7th Floor, 50 Broadway,
  London
  X0
  SW1H 0D
  Common shares
  11/20/2024
  10945
  125758.05
  The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/25/2024.
  12/20/2024
  06/25/2024
  Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker